Initial Hemopurification Strategy for Acute Paraquat Poisoning in Adults
Anahtar kelimeler
Öz
Açıklama
Patients diagnosed with acute paraquat poisoning in the Emergency Room of the First Affiliated Hospital of Zhengzhou University would be stratified according to their urine dithionite test results and randomly assigned to four different groups: HD, HP, HP-HD and control (conservative therapy) group for different treatment. Arterial blood gas test, complete blood count, coagulation function, liver function, pancreatic function, urine dithionite test, renal function and chest radiographs would be closely monitored during treatment. Primary endpoint is 28-day mortality. Secondary endpoints include (1) survival time (from the time of PQ ingestion to the time of death), all-cause mortality at the 3rd, 7th and 60th day; (2) rate of necessary oxygen uptake and rate of mechanical ventilation; (3) in-hospital length of stay and ICU length of stay; (4) APACHE II score and PSS score; (5) rate of general complications, such as respiratory failure, acute kidney injury (AKI), acute liver failure, pancreas function abnormality and Multiple Organ Failure (MOF); (6) rate of intervention related complications, such as catheter placement related complications, thrombocytopenia and deep venous thrombosis; (7) rate of adverse events, which include unexpected death, severe hemorrhage or edema, unplanned extubation, coagulation in the extracorporeal circulation, blockage of cartridge, incorrect pipe connection, etc.
Tarih
| Son Doğrulandı: | 03/31/2018 |
| İlk Gönderilen: | 10/09/2017 |
| Tahmini Kayıt Gönderildi: | 10/14/2017 |
| İlk Gönderilen: | 10/18/2017 |
| Son Güncelleme Gönderildi: | 04/11/2018 |
| Son Güncelleme Gönderildi: | 04/16/2018 |
| Fiili Çalışma Başlangıç Tarihi: | 09/30/2018 |
| Tahmini Birincil Tamamlanma Tarihi: | 12/30/2021 |
| Tahmini Çalışma Tamamlanma Tarihi: | 02/27/2022 |
Durum veya hastalık
Müdahale / tedavi
Procedure: Hemodialysis (HD)
Procedure: Hemoperfusion (HP)
Procedure: HP-HD
Evre
Kol Grupları
| Kol | Müdahale / tedavi |
|---|---|
| Experimental: Hemodialysis (HD) Patients in this group would receive hemodialysis for 3 days consecutively besides conservative therapy. | Procedure: Hemodialysis (HD) Participants in this group will be catheterize in the internal jugular vein and connect to a hemodialysis machine. |
| Experimental: Hemoperfusion (HP) Patients in this group would receive hemoperfusion for 3 days consecutively besides conservative therapy. | Procedure: Hemoperfusion (HP) Participants in this group will be catheterize in the internal jugular vein and connect to a hemoperfusion machine. |
| Experimental: HP-HD Patients in this group would receive hemoperfusion and hemodialysis concurrent therapy for 3 days consecutively besides conservative therapy. | Procedure: HP-HD Participants in this group will be catheterize in the internal jugular vein and connect to a hemoperfusion machine and then a hemodialysis machine for one course. |
| No Intervention: Conservative Patients in this group would receive basic supportive treatment, gastric lavage, glucosteroid and immunosuppressive drugs without any hemopurification. |
Uygunluk kriterleri
| Çalışmaya Uygun Yaşlar | 18 Years İçin 18 Years |
| Çalışmaya Uygun Cinsiyetler | All |
| Sağlıklı Gönüllüleri Kabul Ediyor | Evet |
| Kriterler | Inclusion Criteria: - Suspected paraquat ingestion history (intended or accidental), which is confirmed by positive urine dithionite result (light blue, navy blue and dark blue). - Arriving at the ER within 24 hours after PQ digestion. - No known current pregnancy or lactation. - Absence of cardiac arrest after poisoning, and no previous or present history of chronic kidney disease, chronic liver disease, respiratory failure, COPD, asthma, heart failure, pancreatic disease, acute coronary syndrome (ACS) or stoke. - No known combined ingestion with other poisons or alcohol. - No previous blood purification treatment prior to admission. - No known participation in other medical trials. - Agreement on informed consent. Exclusion Criteria: - Patients who are unable to comply with the procedures of the present trial, including those who change therapy or withdraw treatment. - Patients who develop severe allergic response to HP materials. - Patients who do not receive intervention within 4 hours after admission in reality. |
Sonuç
Birincil Sonuç Ölçütleri
1. 28-day all-cause mortality [From the day of intoxication to the 28th day afterwards.]
İkincil Sonuç Ölçütleri
1. Survival time [From the day of intoxication to death or the 60th day.]
2. Rate of multiple organ failure [From the day of intoxication to death or the 60th day.]
3. Rate of oxygen uptake [From the day of intoxication to death or the 60th day.]
4. Rate of mechanical ventilation [From the day of intoxication to death or the 60th day.]
5. In-hospital length of stay [From the day of admission to discharge or up to 60 days after admission.]
6. 3-day all-cause mortality [From the day of intoxication to the 3rd day afterwards.]
7. 7-day all-cause mortality [From the day of intoxication to the 7th day afterwards.]
8. 60-day all-cause mortality [From the day of intoxication to the 60th day afterwards.]
9. ICU length of stay [From the day of intoxication to death or the 60th day.]
10. Rate of catheter related complications [From the day of intoxication to death or the 60th day.]
